Extended Reality (XR)-Assisted CT Localization of Pulmonary Nodules
1 other identifier
interventional
30
0 countries
N/A
Brief Summary
Extended Reality (XR)-Assisted CT Localization of Pulmonary Nodules
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2026
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 5, 2026
CompletedFirst Posted
Study publicly available on registry
February 25, 2026
CompletedStudy Start
First participant enrolled
March 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
February 25, 2026
February 1, 2026
9 months
February 5, 2026
February 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Localization accuracy
Procedures in this study will be conducted in a CT room. The accuracy of XR-assisted CT-guided localization will be assessed immediately after localization by employing in-room CT to determine the needle tip position and measure the distance to the target tumor.
Immediatedly after Extended Reality (XR)-Assisted CT-Guided Localization
Secondary Outcomes (1)
Assessment of perioperative outcomes
The study assessment time frame from XR-assisted CT-guided localization to discharge is approximately 3 to 7 days.
Study Arms (1)
Extended Reality (XR)-Assisted CT Localization of Pulmonary Nodules
EXPERIMENTALInterventions
This study plans to collect approximately 30 localization cases from multiple centers within our institution. First, after patient positioning and immobilization in the computed tomography (CT) suite, a chest CT scan is performed. Imaging data are processed using semi-automatic segmentation and rapid reconstruction techniques to generate, in real time, a three-dimensional model that corresponds to the patient's current localization position. During the construction of the three-dimensional model, patients remain in a fixed position. To reduce anxiety and discomfort associated with waiting, patient education related to pulmonary nodule localization and thoracoscopic surgery is provided during this period. The educational content includes the purpose of the procedure, procedural steps, potential risks, and key points of postoperative care. Once model construction is completed, a metaverse-based XR platform is used in the same setting to overlay the digital twin model onto the patient's
Eligibility Criteria
You may qualify if:
- Patients aged between 18 and 80 who are scheduled to undergo lung nodule resection surgery.
- Patients with lung nodules smaller than 2 cm that require preoperative localization.
- Patients with lung nodules located in the outer one-third of the lung.
You may not qualify if:
- Patients requiring lobectomy.
- Patients who have not provided written informed consent.
- Vulnerable populations.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 5, 2026
First Posted
February 25, 2026
Study Start
March 1, 2026
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
February 25, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
De-identified individual participant data (IPD) collected during this study will generally not be shared with other researchers, primarily due to patient privacy considerations. However, limited access to de-identified IPD may be considered in exceptional cases upon a reasonable request.